Skip to main content
Premium Trial:

Request an Annual Quote

In the Blood

Lasker Award winner David Weatherall became interested in genetic blood diseases while doing his compulsory military service in Singapore where he treated a Nepalese girl with anemia — she had thalessemia, which had been throught to only affect people of Mediterranean heritage. As he tells the New York Times' Claudia Dreifus, following his military service, Weatherall was "hooked" and went to Johns Hopkins. There, he and his colleagues discovered that there are two types of the disease that differ in whether the defect is in the alpha or the beta chain. He says that with his Lakser winnings, he'll continue his research. "I want to look into a form of Asian thalassemia where there's a strong hint that a high proportion of the kids might be able to go through their lives with low hemoglobin and without transfusions," he says. "We don't know if this is genetic or perhaps something about their environment. That's what I'd like to sort out before I depart. And that's what the prize will probably finance."

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.